Why Is UNH Stock Soaring After Earnings?
UnitedHealth beat expectations for the first quarter, sending UNH stock up over 5%. Here's what you need to know.
UnitedHealth Group (UNH) stock is soaring over 5% in Tuesday's session after the company beat both earnings and revenue estimates for its fiscal 2024 first quarter.
UNH stock can certainly use the boost considering it was down 15% for the year-to-date heading into today's trading. This makes it one of the worst Dow Jones stocks of 2024 so far.
The company reported revenue of $99.8 billion and adjusted earnings of $6.91 per share for the three months ended March 31, which exceeded analysts' estimates of $99.3 billion and $6.61 per share, respectively. On a year-over-year basis, UnitedHealth's revenue increased 8.6% and its adjusted earnings per share (EPS) were up 10.4%.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Also in the quarter, UnitedHealth's medical care ratio (MCR) expanded 210 basis points to 84.3% from 82.2% in the year-ago period, which it said was due to "revenue effects of the Medicare funding reductions, considerations driven by the Change Healthcare cyberattack, including accommodations to support care providers, medical reserve and development effects, and business mix."
The MCR measures medical costs as a percentage of premium revenue, and the lower the figure, the better.
UnitedHealth's adjusted EPS does not include a $683 million impact or approximately 74 cents per share, net of tax, incurred from a cyberattack at its Change Healthcare unit. For the full year, the company expects the impact to be between $1.15 per share and $1.35 per share.
"The core story at UnitedHealth Group remains our colleagues delivering improved experiences for the people we serve and driving balanced growth even while swiftly and effectively addressing the attack on Change Healthcare," UnitedHealth CEO Andrew Witty said in a statement.
As a result of its strong performance in the first quarter, UnitedHealth maintained its full-year adjusted EPS outlook of $27.50 to $28.00.
Earnings season is just getting started
The earnings calendar is heating up as the season gets rolling. After the market closes today, we'll get earnings reports from United Airlines (UAL), J.B. Hunt Transport (JBHT) and Interactive Brokers (IBKR), amongst others.
And before the market opens tomorrow, we'll get reports from ASML (ASML), Travelers Companies (TRV), Abbott Laboratories (ABT) and Prologis (PLD), amongst others.
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Amazon’s Try Before You Buy Is Ending — Here Are the Best Alternatives in 2025
Amazon is ending its Try Before You Buy program on January 31, but you still have options. Discover the best alternatives, including clothing, eyewear and styling services.
By Brittany Leitner Published
-
Stock Market Today: Stocks Slip as Inflation Worries Rise
Concerns over price pressures are growing ahead of next week's Fed meeting.
By Karee Venema Published
-
Stock Market Today: Stocks Slip as Inflation Worries Rise
Concerns over price pressures are growing ahead of next week's Fed meeting.
By Karee Venema Published
-
Twilio Stock Soars on Strong Profit Forecasts: What to Know
Twilio stock is one of the best-performing stocks Friday after the tech company revealed its three-year profit forecast at an investor event.
By Joey Solitro Published
-
Novo Nordisk Stock Surges On Weight Loss Drug Data and Analysts Say It's Still a Buy
Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight loss drug. Here's what you need to know.
By Joey Solitro Published
-
Verizon Sails to the Top of the Dow After Earnings Beat: What to Know
Verizon stock is one of the best Dow Jones stocks Friday after the telecommunications giant beat estimates for its fourth quarter. Here's what you need to know.
By Joey Solitro Published
-
What American Express' Latest Dividend Hike Means for Investors
In addition to an earnings beat, American Express disclosed a 17% increase to its quarterly dividend. Here's what that means for the Dow Jones stock.
By Joey Solitro Published
-
Secure Your Retirement Paycheck: The Power of Three Buckets
Putting all of your nest egg in one basket is risky. Try putting it in three buckets for short-term, medium-term and long-term needs instead.
By Pete Tychsen, Investment Adviser Representative Published
-
Five Reasons You Might Hate Your Insurance Company (and Why You Shouldn't)
Stories about insurance companies letting down their customers are easy to come by, but there's another side to many of those stories.
By Karl Susman, CPCU, LUTCF, CIC, CSFP, CFS, CPIA, AAI-M, PLCS Published
-
Stock Market Today: Dow Adds 408 Points as Trump Answers Davos Questions
Tech stocks surged late and the S&P 500 established its first new all-time closing high of 2025.
By David Dittman Published